A CLINICAL STUDY ON THE MANAGEMENT OF PEENASA WITH CHITRAKA HARITAKI LEHYA

Dr. Gururaj Anil Bhat* and Dr. Chaitra H.

ABSTRACT

Peenasa is characterized by nasa avarodha (nasal obstruction), nasa shosha (dryness of the nose), nasal discharge and gandha ajnana (abnormal perception of the smell). It is considered to be vatakapha predominant disease. It is not life threatening condition but it can produce difficulty in carrying out day to day routine activities and there by greatly affecting the quality of life. The signs and symptoms of Peenasa were categorized into mild, moderate and severe. The drug Chitraka Haritaki Lehya mentioned in Nasa rogadhikara chikitsa in the text Chakradutta selected for the present clinical trial in Peenasa. The ingredients present in this drug helps in alleviating the disorder by breaking down the pathogenesis. Twenty patients received Chitraka Haritaki Lehya internally in the dose of 10 grams, twice daily after food for a period of 7 days. Nasal discharge (50%) and nasal obstruction (28%) were relieved in maximum patients and the least response was observed in the abnormal perception of smell i.e. 10.5% and the other symptoms had moderate relief.

Keywords: peenasa, ama, atrophic rhinitis.